Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Pancreas. 2018 Feb;47(2):208–212. doi: 10.1097/MPA.0000000000000985

TABLE 2.

Multivariable Competing Risk Analysis

Characteristic HR (95 % CI) P
Local failure
 Smad4 loss tumor* 2.37 (1.10–5.11) 0.027
 Lymph node ratio 3.36 (2.02–5.58) <0.0001
 Positive surgical margins 0.99 (0.48–2.08) 0.99
 Tumor size, cm 1.10 (0.82–1.47) 0.52
Distant failure
 Smad4 loss tumor* 1.71 (1.03–2.83) 0.037
 Lymph node ratio 0.65 (0.41–1.04) 0.07
 Positive surgical margins 1.94 (1.20–3.12) 0.0065
 Tumor size, cm 1.28 (1.04–1.58) 0.02
 Histologic grade 3/4 1.14 (0.71–1.84) 0.59
*

By immunolabeling